Cargando…
Biomarkers for Pancreatic Neuroendocrine Neoplasms (PanNENs) Management—An Updated Review
Pancreatic neuroendocrine tumors (PanNENs) are rare sporadic cancers or develop as part of hereditary syndromes. PanNENs can be both functioning and non-functioning based on whether they produce bioactive peptides. Some PanNENs are well differentiated while others—poorly. Symptoms, thus, depend on b...
Autores principales: | Bocchini, Martine, Nicolini, Fabio, Severi, Stefano, Bongiovanni, Alberto, Ibrahim, Toni, Simonetti, Giorgia, Grassi, Ilaria, Mazza, Massimiliano |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7267066/ https://www.ncbi.nlm.nih.gov/pubmed/32537434 http://dx.doi.org/10.3389/fonc.2020.00831 |
Ejemplares similares
-
EZH2 Inhibition as New Epigenetic Treatment Option for Pancreatic Neuroendocrine Neoplasms (PanNENs)
por: April-Monn, Simon Leonhard, et al.
Publicado: (2021) -
A novel liver metastasis-correlated protein of pancreatic neuroendocrine neoplasm (PanNEN) discovered by proteomic analysis
por: Shimura, Mitsuhiro, et al.
Publicado: (2018) -
The characteristics of serum lipid spectrum in PanNENs and its correlation with clinicopathological features and prognosis
por: Meng, Yu-Fan, et al.
Publicado: (2023) -
Phase-II Trials of Pazopanib in Metastatic Neuroendocrine Neoplasia (mNEN): A Systematic Review and Meta-Analysis
por: Bongiovanni, Alberto, et al.
Publicado: (2020) -
Activity and Safety of Immune Checkpoint Inhibitors in Neuroendocrine Neoplasms: A Systematic Review and Meta-Analysis
por: Bongiovanni, Alberto, et al.
Publicado: (2021)